Development of a points to consider document for human somatic cell gene therapy.
D026683:Advisory Committees; D004274:DNA, Recombinant / Q000627:therapeutic use*; D026724:Ethical Review; D028744:Ethics Committees, Research; D004992:Ethics, Medical; D035082:Federal Government; D005796:Genes; D005818:Genetic Engineering; D033161:Government Regulation; D006801:Humans; D009316:National Institutes of Health (U.S.); D018579:Patient Selection; D035842:Research Subjects; D014481:United States
D004274:DNA, Recombinant